Key Insights
The India contraceptive devices market, valued at approximately ₹15000 million (estimated based on available data and industry trends) in 2025, is projected to experience robust growth, exhibiting a Compound Annual Growth Rate (CAGR) of 7.42% from 2025 to 2033. This expansion is fueled by several key drivers. Increasing awareness of family planning and reproductive health, coupled with government initiatives promoting contraceptive usage, are significantly impacting market growth. Furthermore, rising urbanization and changing lifestyles are contributing to a greater demand for diverse contraceptive options. The market is segmented by type (condoms, IUDs, diaphragms, etc.) and gender, reflecting the varied needs of the population. While the market benefits from increased access to information and healthcare services, challenges remain, including regional disparities in access to contraceptives, particularly in rural areas, and persistent social stigma surrounding family planning. The growth trajectory is likely to be influenced by evolving government policies, advancements in contraceptive technology, and ongoing educational campaigns aimed at improving contraceptive literacy.
A key aspect of market segmentation involves the distinct preferences and needs of male and female consumers. Condoms remain a dominant segment within the male contraceptive market, while the female segment witnesses increased demand for IUDs, pills and other long-acting reversible contraceptives (LARC). The competitive landscape comprises both established multinational corporations and domestic players, vying to cater to this expanding market. Competition is expected to intensify, driving innovation and potentially leading to more affordable and accessible contraceptive options. The significant growth potential makes India a focal point for contraceptive device manufacturers, prompting both strategic investments and new product introductions within the market.

India Contraceptive Devices Industry: Market Report 2019-2033
This comprehensive report provides a detailed analysis of the India contraceptive devices market, offering invaluable insights for industry stakeholders, investors, and researchers. Covering the period 2019-2033, with a focus on 2025, this report unravels market dynamics, trends, and future prospects, highlighting key players and emerging opportunities within this vital sector. The report utilizes robust data and in-depth analysis to offer actionable strategic recommendations.
India Contraceptive Devices Industry Market Dynamics & Concentration
The Indian contraceptive devices market exhibits a moderately concentrated landscape, with key players such as AbbVie Inc (Allergan PLC), Church & Dwight Co Inc, Bayer AG, Merck & Co Inc, CooperSurgical Inc, The Female Health Company, Johnson & Johnson, Lupin Pharmaceuticals Ltd, Mayer Laboratories Inc, Viatris (Mylan Laboratories), and Pfizer Inc holding significant market share. However, the presence of numerous smaller domestic players contributes to a dynamic competitive environment. Market concentration is estimated at xx% in 2025, driven by the increasing consolidation through mergers and acquisitions (M&A). The number of M&A deals within the sector has shown a xx% increase from 2019 to 2024.
- Innovation Drivers: Government initiatives promoting family planning, technological advancements in device design and manufacturing, and rising awareness of sexual and reproductive health are key innovation drivers.
- Regulatory Framework: The regulatory landscape influences product approvals and market entry, creating both opportunities and challenges for players. Stringent quality control and safety standards are in place.
- Product Substitutes: The availability of various contraceptive methods, including surgical sterilization and traditional methods, presents a competitive landscape for the devices market.
- End-User Trends: Changing consumer preferences towards convenience, efficacy, and discreetness are influencing product demand. Growing female empowerment and access to information are also significant factors.
India Contraceptive Devices Industry Industry Trends & Analysis
The Indian contraceptive devices market is projected to experience robust growth, with a CAGR of xx% during the forecast period (2025-2033). This growth is fuelled by several factors: increasing awareness of family planning, rising disposable incomes, government support for reproductive healthcare programs, and increasing urbanization. Market penetration for various contraceptive methods remains relatively low, indicating significant untapped potential. Technological advancements, including the introduction of new and improved devices, are further driving market expansion. Competitive dynamics are characterized by both established multinational players and a growing number of domestic manufacturers. The market is witnessing a shift toward more convenient and user-friendly products, catering to the evolving needs and preferences of consumers.

Leading Markets & Segments in India Contraceptive Devices Industry
The condom segment dominates the Indian contraceptive devices market by type, driven by its affordability, accessibility, and widespread availability. The female segment shows higher usage compared to the male segment, with IUDs and other hormonal contraceptives gaining popularity.
By Type:
- Condoms: High market share attributed to affordability, accessibility, and widespread awareness.
- IUDs: Growing preference driven by long-term efficacy and convenience.
- Other Devices: This category shows potential for growth, driven by innovations and increased marketing.
By Gender:
- Female: Higher market share due to greater awareness and accessibility of female contraceptive options.
- Male: Lower market share, with potential for growth via increased awareness campaigns and product innovation.
Key Drivers:
- Government Initiatives: National family planning programs and initiatives promoting reproductive health awareness.
- Rising Disposable Incomes: Increased purchasing power, particularly in urban areas.
- Improved Healthcare Infrastructure: Increased access to healthcare services, particularly in rural areas.
India Contraceptive Devices Industry Product Developments
Recent innovations focus on enhancing product efficacy, user experience, and convenience. Technological advances have led to the development of new materials, designs, and formulations, addressing issues such as comfort and ease of use. The market is witnessing a trend toward user-friendly, discreet, and long-acting contraceptives. Companies are competing on the basis of product features, pricing, and brand reputation.
Key Drivers of India Contraceptive Devices Industry Growth
The growth of the Indian contraceptive devices market is being propelled by several key factors:
- Government Support: Continued government investment in family planning initiatives and increased healthcare access.
- Technological Advancements: Development of newer, more effective, and user-friendly contraceptive devices.
- Rising Awareness: Improved education and awareness regarding family planning and reproductive health.
- Economic Growth: Increased disposable incomes and improved healthcare infrastructure leading to increased purchasing power.
Challenges in the India Contraceptive Devices Industry Market
The market faces several challenges, including:
- Regulatory Hurdles: Navigating complex regulatory requirements for product approvals and distribution.
- Supply Chain Issues: Ensuring consistent and reliable supply of raw materials and finished products.
- Competition: Intense competition from both domestic and international players.
- Accessibility: Ensuring widespread access to contraceptive devices, especially in rural areas.
Emerging Opportunities in India Contraceptive Devices Industry
The market presents significant growth opportunities, driven by:
- Technological Advancements: Development of advanced contraceptive technologies such as long-acting reversible contraceptives (LARCs).
- Strategic Partnerships: Collaborations between public and private sectors to improve access and affordability.
- Market Expansion: Reaching untapped markets in rural and underserved areas.
- Digital Marketing: Leveraging digital platforms to reach and engage consumers.
Leading Players in the India Contraceptive Devices Industry Sector
- AbbVie Inc (Allergan PLC)
- Church & Dwight Co Inc
- Bayer AG
- Merck & Co Inc
- CooperSurgical Inc
- The Female Health Company
- Johnson & Johnson
- Lupin Pharmaceuticals Ltd
- Mayer Laboratories Inc
- Viatris (Mylan Laboratories)
- Pfizer Inc
Key Milestones in India Contraceptive Devices Industry Industry
- January 2022: The Durex-supported Condom Alliance partnered with the MASH Project Foundation to raise awareness about sexual health and safe sex.
- April 2022: Durex launched its new condom offering, Durex Intense, in India.
Strategic Outlook for India Contraceptive Devices Industry Market
The Indian contraceptive devices market holds immense potential for growth, driven by ongoing technological innovation, increasing government support, and evolving consumer preferences. Strategic partnerships, investments in R&D, and targeted marketing campaigns will be crucial for players seeking to capitalize on this opportunity. The market is poised for sustained expansion, driven by both unmet needs and evolving consumer demand for newer, more effective, and user-friendly contraceptive solutions.
India Contraceptive Devices Industry Segmentation
-
1. Type
- 1.1. Condoms
- 1.2. Diaphragms
- 1.3. Cervical Caps
- 1.4. Sponges
- 1.5. Vaginal Rings
- 1.6. Intra Uterine Devices (IUD)
- 1.7. Other Devices
-
2. Gender
- 2.1. Male
- 2.2. Female
India Contraceptive Devices Industry Segmentation By Geography
- 1. India

India Contraceptive Devices Industry REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 7.42% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Incidences of the STDs; Increasing Rate of Unintended Pregnancies
- 3.3. Market Restrains
- 3.3.1. High Cost of Devices and Treatment; Side Effects Associated with the Use of Contraceptive Devices
- 3.4. Market Trends
- 3.4.1. Condoms Segment is Expected to Hold Significant Market Share in the India Contraceptive Devices Market Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. India Contraceptive Devices Industry Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Condoms
- 5.1.2. Diaphragms
- 5.1.3. Cervical Caps
- 5.1.4. Sponges
- 5.1.5. Vaginal Rings
- 5.1.6. Intra Uterine Devices (IUD)
- 5.1.7. Other Devices
- 5.2. Market Analysis, Insights and Forecast - by Gender
- 5.2.1. Male
- 5.2.2. Female
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. India
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. North India India Contraceptive Devices Industry Analysis, Insights and Forecast, 2019-2031
- 7. South India India Contraceptive Devices Industry Analysis, Insights and Forecast, 2019-2031
- 8. East India India Contraceptive Devices Industry Analysis, Insights and Forecast, 2019-2031
- 9. West India India Contraceptive Devices Industry Analysis, Insights and Forecast, 2019-2031
- 10. Competitive Analysis
- 10.1. Market Share Analysis 2024
- 10.2. Company Profiles
- 10.2.1 AbbVie Inc (Allergan PLC)
- 10.2.1.1. Overview
- 10.2.1.2. Products
- 10.2.1.3. SWOT Analysis
- 10.2.1.4. Recent Developments
- 10.2.1.5. Financials (Based on Availability)
- 10.2.2 Church & Dwight Co Inc
- 10.2.2.1. Overview
- 10.2.2.2. Products
- 10.2.2.3. SWOT Analysis
- 10.2.2.4. Recent Developments
- 10.2.2.5. Financials (Based on Availability)
- 10.2.3 Bayer AG
- 10.2.3.1. Overview
- 10.2.3.2. Products
- 10.2.3.3. SWOT Analysis
- 10.2.3.4. Recent Developments
- 10.2.3.5. Financials (Based on Availability)
- 10.2.4 Merck & Co Inc
- 10.2.4.1. Overview
- 10.2.4.2. Products
- 10.2.4.3. SWOT Analysis
- 10.2.4.4. Recent Developments
- 10.2.4.5. Financials (Based on Availability)
- 10.2.5 CooperSurgical Inc
- 10.2.5.1. Overview
- 10.2.5.2. Products
- 10.2.5.3. SWOT Analysis
- 10.2.5.4. Recent Developments
- 10.2.5.5. Financials (Based on Availability)
- 10.2.6 The Female Health Company
- 10.2.6.1. Overview
- 10.2.6.2. Products
- 10.2.6.3. SWOT Analysis
- 10.2.6.4. Recent Developments
- 10.2.6.5. Financials (Based on Availability)
- 10.2.7 Johnson & Johnson
- 10.2.7.1. Overview
- 10.2.7.2. Products
- 10.2.7.3. SWOT Analysis
- 10.2.7.4. Recent Developments
- 10.2.7.5. Financials (Based on Availability)
- 10.2.8 Lupin Pharmaceuticals Ltd
- 10.2.8.1. Overview
- 10.2.8.2. Products
- 10.2.8.3. SWOT Analysis
- 10.2.8.4. Recent Developments
- 10.2.8.5. Financials (Based on Availability)
- 10.2.9 Mayer Laboratories Inc*List Not Exhaustive
- 10.2.9.1. Overview
- 10.2.9.2. Products
- 10.2.9.3. SWOT Analysis
- 10.2.9.4. Recent Developments
- 10.2.9.5. Financials (Based on Availability)
- 10.2.10 Viatris (Mylan Laboratories)
- 10.2.10.1. Overview
- 10.2.10.2. Products
- 10.2.10.3. SWOT Analysis
- 10.2.10.4. Recent Developments
- 10.2.10.5. Financials (Based on Availability)
- 10.2.11 Pfizer Inc
- 10.2.11.1. Overview
- 10.2.11.2. Products
- 10.2.11.3. SWOT Analysis
- 10.2.11.4. Recent Developments
- 10.2.11.5. Financials (Based on Availability)
- 10.2.1 AbbVie Inc (Allergan PLC)
List of Figures
- Figure 1: India Contraceptive Devices Industry Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: India Contraceptive Devices Industry Share (%) by Company 2024
List of Tables
- Table 1: India Contraceptive Devices Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 2: India Contraceptive Devices Industry Revenue Million Forecast, by Type 2019 & 2032
- Table 3: India Contraceptive Devices Industry Revenue Million Forecast, by Gender 2019 & 2032
- Table 4: India Contraceptive Devices Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 5: India Contraceptive Devices Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 6: North India India Contraceptive Devices Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 7: South India India Contraceptive Devices Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: East India India Contraceptive Devices Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: West India India Contraceptive Devices Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: India Contraceptive Devices Industry Revenue Million Forecast, by Type 2019 & 2032
- Table 11: India Contraceptive Devices Industry Revenue Million Forecast, by Gender 2019 & 2032
- Table 12: India Contraceptive Devices Industry Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the India Contraceptive Devices Industry?
The projected CAGR is approximately 7.42%.
2. Which companies are prominent players in the India Contraceptive Devices Industry?
Key companies in the market include AbbVie Inc (Allergan PLC), Church & Dwight Co Inc, Bayer AG, Merck & Co Inc, CooperSurgical Inc, The Female Health Company, Johnson & Johnson, Lupin Pharmaceuticals Ltd, Mayer Laboratories Inc*List Not Exhaustive, Viatris (Mylan Laboratories), Pfizer Inc.
3. What are the main segments of the India Contraceptive Devices Industry?
The market segments include Type, Gender.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Incidences of the STDs; Increasing Rate of Unintended Pregnancies.
6. What are the notable trends driving market growth?
Condoms Segment is Expected to Hold Significant Market Share in the India Contraceptive Devices Market Over the Forecast Period.
7. Are there any restraints impacting market growth?
High Cost of Devices and Treatment; Side Effects Associated with the Use of Contraceptive Devices.
8. Can you provide examples of recent developments in the market?
April 2022- Durex launched its new offering in the condom category called Durex Intense in India.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "India Contraceptive Devices Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the India Contraceptive Devices Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the India Contraceptive Devices Industry?
To stay informed about further developments, trends, and reports in the India Contraceptive Devices Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence